17 Results for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Transforming The Medical Device Industry: Road Map To A Circular EconomyHealth affairs (Millwood, Va.), 2020-12, Vol.39 (12), p.2088-2097 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Dec 2020 ;ISSN: 0278-2715 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2020.01118Full text available |
| 2 |
Material Type: Article
|
|
Defining the concept of fair pricing for medicinesBMJ (Online), 2020-01, Vol.368, p.l4726-l4726 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed under the terms of the Creative Commons Attribution IGO License (https://creativecommons.org/licenses/by-nc/3.0/igo/), which permits use, distribution, and reproduction for non-commercial purposes in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l4726 ;PMID: 31932334Full text available |
| 3 |
Material Type: Article
|
|
The role of biosimilars in the treatment of rheumatic diseasesAnnals of the Rheumatic Diseases, 2013-03, Vol.72 (3), p.322-328 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-202715 ;PMID: 23253920 ;CODEN: ARDIAOFull text available |
| 4 |
Material Type: Article
|
|
Open-source hardware for medical devicesBMJ innovations, 2016-04, Vol.2 (2), p.78-83 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 2055-8074 ;ISSN: 2055-642X ;EISSN: 2055-642X ;DOI: 10.1136/bmjinnov-2015-000080 ;PMID: 27158528Full text available |
| 5 |
Material Type: Article
|
|
Recent Experience In Health Promotion At Johnson & Johnson: Lower Health Spending, Strong Return On InvestmentHealth Affairs, 2011-03, Vol.30 (3), p.490-499 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Mar 2011 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2010.0806Full text available |
| 6 |
Material Type: Article
|
|
The world needs to prepare now to prevent polio resurgence post eradicationBMJ global health, 2022-12, Vol.7 (12), p.e011485 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2059-7908 ;EISSN: 2059-7908 ;DOI: 10.1136/bmjgh-2022-011485 ;PMID: 36581335Full text available |
| 7 |
Material Type: Article
|
|
Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseasesBMJ global health, 2023-09, Vol.8 (9), p.e012855 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. 2023 ;ISSN: 2059-7908 ;EISSN: 2059-7908 ;DOI: 10.1136/bmjgh-2023-012855 ;PMID: 37696544Full text available |
| 8 |
Material Type: Article
|
|
Biosimilar Competition In The United States: Statutory Incentives, Payers, And Pharmacy Benefit ManagersHealth Affairs, 2015-02, Vol.34 (2), p.294-301 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Feb 2015 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2014.0482Full text available |
| 9 |
Material Type: Article
|
|
Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich CountriesHealth Affairs, 2016-02, Vol.35 (2), p.227-234 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Feb 2016 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2015.1411Full text available |
| 10 |
Material Type: Article
|
|
Development of a low-dose fast-dissolving tablet formulation of Newcastle disease vaccine for low-cost backyard poultry immunisationVeterinary record, 2014-05, Vol.174 (20), p.504-504 [Peer Reviewed Journal]British Veterinary Association ;British Veterinary Association 2013 ;British Veterinary Association. ;Copyright: 2014 British Veterinary Association ;ISSN: 0042-4900 ;ISSN: 2042-7670 ;EISSN: 2042-7670 ;DOI: 10.1136/vr.101926 ;PMID: 24591479Full text available |
| 11 |
Material Type: Article
|
|
Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatmentBMJ global health, 2018-05, Vol.3 (3), p.e000651-e000651 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 ;ISSN: 2059-7908 ;EISSN: 2059-7908 ;DOI: 10.1136/bmjgh-2017-000651 ;PMID: 29862054Full text available |
| 12 |
Material Type: Article
|
|
Drug companies lobby against generic versions of biologicsBMJ (Online), 2013-02, Vol.346 (feb04 2), p.f740-f740 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2013 ;Copyright: 2013 © BMJ Publishing Group Ltd 2013 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.f740 ;PMID: 23381589Full text available |
| 13 |
Material Type: Article
|
|
Employer-based health insurance in a changing work forceHealth Affairs, 1994, Vol.13 (1), p.315-326 [Peer Reviewed Journal]Copyright Project Hope Spring 1994 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.13.1.315 ;PMID: 8188151Full text available |
| 14 |
Material Type: Article
|
|
The promise of managed care: an insurer's perspectiveHealth Affairs, 1991, Vol.10 (4), p.185-188 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Winter 1991 ;ISSN: 0278-2715 ;EISSN: 2694-233X ;EISSN: 1544-5208 ;DOI: 10.1377/hlthaff.10.4.185 ;PMID: 1778554Full text available |
| 15 |
Material Type: Article
|
|
I. CONFERENCE SUMMARY: Pharmaceuticals In Developing CountriesHealth affairs (Millwood, Va.), 1988-10, Vol.7 (4), p.175-179 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Fall 1988 ;ISSN: 0278-2715 ;EISSN: 2694-233XFull text available |
| 16 |
Material Type: Article
|
|
Quality Of Care Research And Projects In ProgressHealth affairs (Millwood, Va.), 1988-04, Vol.7 (1), p.145-150 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Spring 1988 ;ISSN: 0278-2715 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.7.1.145Full text available |
| 17 |
Material Type: Article
|
|
Review of capital needs studyHealth Affairs, 1982, Vol.1 (4), p.111-115 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Fall 1982 ;ISSN: 0278-2715 ;EISSN: 2694-233X ;EISSN: 1544-5208 ;DOI: 10.1377/hlthaff.1.4.111 ;PMID: 10258609Full text available |
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 1988 (2)
- 1988 To 1993 (3)
- 1994 To 2012 (2)
- 2013 To 2015 (4)
- After 2015 (7)
-
More options
Subject
- Cost Control (15)
- Life Sciences & Biomedicine (14)
- Science & Technology (14)
- Manufacturers (10)
- Humans (9)
- Health Policy & Services (7)
- Health Care Sciences & Services (7)
- United States (6)
- Health Care Expenditures (5)
- Vaccines (4)
- Public Health (4)
- Prices (4)
- Generic Drugs (4)
- Health Care Policy (4)
- Global Health (4)
- Health Care Industry (3)
- Biological Products (3)
- Health Care (3)
- Health Services (3)
-
More options
Databases
Journal Title
- Annals Of The Rheumatic Diseases (1)
- Bmj (2)
- Bmj Global Health (3)
- Bmj Innovations (1)
- Health Affairs (9)
- Health Affairs Web Exclusive (4)
- The Bmj (1)
- Veterinary Record (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||